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THE LEVEL AND THE PERSISTENCE OF ISLET 
CELL ANTIBODIES IN HEALTHY 
SCHOOLCHILDREN ARE ASSOCIATED WITH 
POLYMORPHIC RESIDUES OF THE HLA-DQß 
CHAIN 
BERNHARD O. BOEHM*, JOCHEN SElßLERf, MICHAEL G L U C K f , BURKHARD J. MANFRASf, 
HELKE THOMASt, KURT SCHMIDT*, WILLIAM A. RUDERTj, KLAUS HENNING USADEL*, 
MASSIMO TRUCCOJ AND WERNER A. SCHERBAUMf 
*University Hospital of F r a n k f u r t M e d i c a l School, Department ofMedicine, F r a n k f u r t , Germany, 
tUniversity Hospital o f U l m M e d i c a l School, Department of Medicine, U l m , Germany, %University of 
Pittshurgh, Children's Hospital, Pittsbwgh, P A , U.S.A. 
Cytoplasmic islet cell antibodies (ICA) were determined in a group of non-diabetic Caucasian 
schoolchildren (w = 4208). The prevalence rate for ICA positivity was 105 per cent (95 per 
cent confidence interval: 0-8-1 -4 per cent). Analysis of H L A risk factors revealed that H L A -
DRB1*03 (/?<001), HLA-DRB1*04 ( p < 0 0 \ ) and H L A haplotypes with non-charged 
amino acids (non-Asp) at codon 57 of the HLA-DQß ( p < 0 - 0 \ ) chain were significantly 
increased when compared to controls. High levels of islet cell antibodies, i.e. Juvenile 
Diabetes Federation units (JDF units) equal to or greater than 30 JDF units were found to be 
associated with amino acids other than aspartic acid at codon 57 of the DQß chain molecule. 
Also the persistence of circulating ICA was found to be associated with non-Asp 
homozygosity of the proband (/?<003). 
KEY WORDS H L A Insulin-dependent diabetes mellitus Islet cell antibodies 
Cytoplasmic islet cell antibodies (ICA) are a major serological hallmark of insulin-
dependent diabetes mellitus ( I D D M ) and prediabetic insulitis. It has been shown in 
family studies that the persistence of I C A over a period of several months, the 
presence of high titer I C A , their complement-fixing ability, and the detection of 
radiobinding insulin autoantibodies are independently correlated with progression 
to I D D M in non-diabetic first-degree relatives (Tarn et a L , 1988; Srikanta et a l . , 
1985; Ziegler et a L , 1990; Riley et a i , 1990). Immunoprecipitating antibodies to the 
64 000 M r (64 K D ) islet cell protein, now recognized as glutamate decarboxylase, 
have been detected in the prediabetic period in first-degree relatives of I D D M 
patients who later developed I D D M (Atkinson et a l . , 1990). However, the laborious 
methods of detection have so far not permitted large-scale testing for 64 K D anti-
bodies, so that I C A are still applied for the primary Screening for I D D M risk. 
Correspondence to: Dr Bernhard O. Boehm, University Hospital of Frankfurt Medical School, Labora-
tory of Molecular Immunology, Theodor-Stern-Kai 7, W-6000 Frankfurt am Main 70, Germany. 
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Genes of the major histocompatibility complex ( M H C ) have been shown to con-
stitute the major part of the immunogenetic background in I D D M patients. More 
than 90 per cent of Caucasian Type 1 diabetic individuals type as H L A - D R B 1 * 0 3 
and/or H L A - D R B P 0 4 (Trucco et a l , 1989). Particular alleles at the H L A - D Q B 1 
locus, which are characterized by the presence or absence of aspartic acid at amino 
acid at position 57 of the D Q ß chain, are even more intimately associated to disease 
susceptibility (Todd et a l . , 1987; Morel et a l , 1988). For this reason, molecular 
typing of the H L A - D Q B 1 alleles now provides a valuable genetic risk marker for 
I D D M in Caucasians (Dorman et a l , 1991). In addition, the Barts-Windsor family 
study has shown that the cumulative risk of a non-diabetic relative is dependent 
on haplotype-sharing of IDDM-associated H L A risk markers with the diabetic 
individual (Tarn et a l , 1988). 
Since most of our present knowledge on the natural course of prediabetic insulitis 
is derived from studies of non-diabetic relatives of I D D M patients, a critical gap 
exists in our knowledge of the epidemiology of I C A and their corresponding risk 
factors in the general population (Boehm et a l . , 1991). Over 90 per cent of newly 
diagnosed I D D M patients lack a family history of the disease, so that an epidemio-
logic approach is required to obtain a clear picture of the risk factors. Only six 
population based studies from Japan, Spain, the Netherlands, Italy, Finland, and 
the U S A have in part addressed this issue so far. A l l studies have provided limited or 
no data on the correlation of I C A with risk factors that had already been established 
for first-degree relatives (reviewed in Lipton et a l . , 1989). 
To address the above questions, we have studied a large group of schoolchildren 
in a homogenous German population, which allowed us to establish prevalence 
rates for I C A positivity. Also, H L A risk factors were measured to analyze their 
association with the presence and the persistence of I C A as well as the I C A levels at a 
given point of time. 
M A T E R I A L S A N D M E T H O D S 
In a cross-sectional study between June 1988 and June 1989, 4208 schoolchildren 
from a homogenous population in the southern part of Germany were screened for 
the presence of I C A in the serum. The total population of schoolchildren comprised 
8031 individuals (3730 males and 4301 females). The medianage was 13-9years; the 
effective ränge 6 to 21 years. The study was performed according to the principles of 
the Declaration of Helsinki. 
Islet cell antibodies (ICA) were determined by indirect immunofluorescence 
testing on unfixed cryostat sections of human pancreas of a donor with blood 
group 0. The high quality of I C A testing was evaluated by the Juvenile Diabetes 
Federation ICA-Workshop (Second J D W I C A Proficiency Program; L A B ID 
No . 116). Results were transferred to Juvenile Diabetes Federation units ( JDF 
units) using the Standard curve of the ICA-Workshop. The lower limit of detection 
in the assay was 5 J D F units throughout the study. 
H L A - D R B 1 phenotypes were determined by the two-color fluorescence tech-
nique according to van Rood and coworkers (1976). H L A - D Q B 1 genotypes were 
analyzed as described (Morel et a l , 1988; Saiki 1987) using i n v i t r o amplified 
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genomic D N A and a panel of sequence specific oligonucleotide probes (SSOs). The 
recent nomenclature for factors of the H L A System was used (Bodmer et a l , 1991). 
Confidence intervals for I C A prevalence were calculated using the Poisson 
distribution. The H L A data were analyzed by the chi-square test; 2 by 2 contingency 
tables were performed, using the Yates correction to estimate the Statistical 
significance (Svejgaard et a l . 9 1980). 
R E S U L T S 
Forty-four out of 4208 individuals (25 males and 19 females) were I C A positive 
(ICA + ). A n overall prevalence of 105 per cent (95 per cent confidence interval: 
0*8-1 -4 per cent) of ICA positivity was observed. 
Thirty-six out of 44 I C A + individuals, 808 local non-diabetic control subjects, 
and 185 local I D D M patients with onset of disease before age 22 were H L A - D R B 1 
phenotyped using serological methods. In addition 36 I C A + schoolchildren, 104 
I D D M patients, and 123 controls were D N A typed. The H L A - D R B 1 *03 (p < 001), 
and the H L A - D R B 1 *04 (p < 001) phenotypes were found to be increased in I C A + 
schoolchildren compared to controls. N o significant difference in the prevalence of 
H L A - D R B 1 types (the following alleles were tested: H L A - D R B 1 *01, *02, *03, *04, 
*05, *06, *07, and *08), could be observed between I D D M patients and the I C A + 
children. The H L A - D Q B 1 D N A analysis showed that 61 1 per cent of the I C A + 
schoolchildren were non-Asp homozygous at codon 57 of the DQß chain or 
non-Asp/'blank'. Of the I C A positive schoolchildren 91 -6 per cent had at least one 
non-Asp H L A haplotype. In contrast, a non-Asp haplotype was found in 71 -5 per 
cent of the local controls (/?<001 when compared to ICA-j-) . A l l I D D M patients 
revealed at least one non-Asp HLA-haplotype and 84-6 per cent were non-Asp 
homozygous. This difference was significant when compared to I C A + subjects 
(p<0-002) as well as the local controls ( p < 0 0 \ ) . The H L A - D N A data are 
summarized in Table 1. 
Three groups were formed in order to analyze the association of ICA levels and 
H L A risk factors. The groups consisted of either H L A - D R B 1*03 + , or H L A -
D R B 1*04+ ('high-risk' H L A factors), or H L A - D R B 1*02 and/or H L A - D R B 1*07 
positive schoolchildren (iow-risk' H L A factors). The rationale behind this strategy 
was to split the I C A + healthy individuals into subgroups with well-known H L A 
risk factors, i.e. H L A - D R B 1*03 and H L A - D R B 1*04, or protective H L A factors, 
i.e. H L A - D R B 1*02 and H L A - D R B 1*07 (Figure 1). The mean I C A level measured 
in J D F units was 5-8 ± 6 1 in D R B 1 *04 + schoolchildren, and 5-9 + 5-1 in D R B 1 *03 
positives. In the group of D R B 1*02 and/or D R B 1*07 positive probands, the mean 
level was found to be 6-6 + 4-5 J D F units. No significant difference was found. 
In summary, no association between the I C A level and any H L A - D R B 1 pheno-
type could be observed. In I C A + , Asp homozygous individuals, the mean level was 
found to be 3-8 ± 3-7 J D F units. Asp/non-Asp heterozygotes revealed a mean titer of 
5-8 ±4-8 J D F units. In contrast, non-Asp homozygotes showed significantly elev-
ated mean I C A levels of 10-3 + 5-3 J D F units. In contrast non-Asp homozygotes 
showed significantly elevated mean I C A levels of 10-3 + 5-3 J D F units (p<0-003) 
when compared to the latter groups (Figure 1). A high level of islet cell antibodies of 
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Table 1. Relation of charged and non-charged amino acids at codon 57 of the HLA-DQß 
chain and ICA positivity 
Haplotype at 
codon 57 
Controls 1CA+ IDDM 
(w= 12) (n = 36) (w= 104) 




Any haplotype including 













Asp: HLA-haplotype with aspartic acid at codon 57 of the DQß chain. Asp+ haplotypes correspond to 
the following HLA-DQB1 alleles: HLA-DQB1*0301, -0303, -0401,-0402, -0503, -0601, and 0602. Non-
Asp: H L A haplotype with a non-charged amino acid at codon 57. Non-asp+ haplotypes correspond to 
the following DQB1 alleles: H L A - D Q B 1*0201, -0302, -0501, -0502, -0504, -0603, -0604, and -0605 (see 
Marsh and Bodmer, 1991). 
The Statistical analysis was done within the local group of controls, IDDM patients, and ICA -I- school-
children. *ICA + versus controls: p < 001; ICA + versus IDDM patients: not significant (NS). **ICA + 
versus controls: NS; ICA+ versus diabetics: NS. ***ICA + versus controls: p < 0 - 0 \ ; ICA+ versus 
IDDM: /><002. ****ICA+ versus controls: p < 0 0\; ICA 4- versus IDDM: NS. 
IDF-units 
DR3* DR4* DR2+/DR7* A3p/Aep Aep/n-Asp n-Asp/n-Asp 
Figure 1. Subgroups of the ICA+ schoolchildren are shown. ICA levels are given as Juvenile Diabetes 
Federation units (+ SEM). A significant difTerence between non-Asp homozygous ICA + schoolchildren 
and Asp-homozygous or non-Asp/Asp-heterozygous individuals was observed (p<0-003). No associ-
ation with H L A - D R B 1 phenotypes can be seen 
>30 J D F units was found in 13 individuals. Three probands had at least one Asp 
positive HLA-haplotype, whereas 10 individuals were non-Asp homozygous. 
Schoolchildren, who were tested as I C A + during the initial survey, were retested 
after 6 months. Their first blood sample was retested together with the second 
sample using the same source of pancreas. I C A were designated as persistent, when 
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Table 2. Persistence of islet cell antibody positivity in relation to codon 57 
of the HLA-DQß chain 
Haplotype at 
codon 57 
ICA negative ICA positive Total 
Asp/Asp 2 1 3 
Asp/non-Asp 6 3 9 
Non-Asp/non-Asp 5 13* 18 
Tolal- 13 17 30 
*Statistically significant, when non-Asp homozygotes are compared to non-Asp/ 
non-Asp heterozygous and Asp homozygous individuals ( p < 0 0 3 ) . 
still positive in a second sample drawn from the proband. Thirty out of 44 initially 
I C A + individuals were tested 6 months after the first I C A analysis. Thirteen (43 per 
cent) schoolchildren were found to be negative, 17 (57 per cent) children positive. 
Seventy-six per cent of these healthy individuals that were persistently I C A + geno-
typed as non-Asp homozygous. Three individuals were heterozygous Asp/non-Asp 
at coden 57 of the DQß chain, and one individual was found to be Asp homozygous 
(Table 2). N o association with H L A - D R phenotypes could be observed. 
D I S C U S S I O N 
A number of studies have examined the prevalence rates of islet cell antibodies in 
dififerent ethnic groups (for review see Lipton and LaPorte, 1989). Prevalence rates 
were found to ränge from 0-24 per cent in Dutch children (Bruining et a l . , 1988); 0-35 
per cent in a Spanish population (Bergua et a l . , 1987) and 4T per cent in a Finnish 
population (Karjalainen, 1990). In our survey, which is the first population study 
where cytoplasmic islet cell antibodies were expressed in J D F units using the 
protocol of the Juvenile Diabetes Federation ICA-Workshop, the prevalence of 
ICA positives was found to be 1 05 per cent with a confidence interval of 0-8 to 1 -4 
per cent. 
While there is much information on factors indicating high risk for the future 
development of I D D M in first-degree relatives of I D D M patients, only limited data 
are available to indicate the possible risk factors in the general population. Since 
more than 90 per cent of I D D M patients lack a family history of I D D M , population 
based data are required. 
So far virtually no information has been provided to calculate the immunogenetic 
risk factors associated with I C A positivity in a random population. The Barts-
Windsor family study showed the high I C A levels as well as complement-fixing I C A 
indicated an increased risk for the future development of I D D M in non-diabetic 
first-degree relatives (Bonifacio et a l , 1990). A n impact of I C A levels on the 
cumulative risk for I D D M has also been shown by Riley and colleagues (1990) in 
Gainsville and in the family study from Boston, which employed the protein A assay 
which is known to detect I C A of 80 J D F units and above (Ziegler et a l , 1990). As is 
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evident in the above mentioned family studies, our survey also showed that ICA 
levels were associated with I D D M specific immunogenetic high-risk markers. 
Our survey shows that immunogenetic risk markers in health I C A + school-
children resemble the immunogenetic background of I D D M patients from the same 
geographic area. We have also confirmed the data from Todd and coworkers (1987), 
who emphasized a strong association of Polymorphie residues of the HLA-DQß 
chain with I D D M in Caucasians. Our immunogenetic data suggest that the genetic 
background of the I C A + children is not completely congruent with the high-risk 
markers found in I D D M patients. The design of the study has excluded I C A + 
non-Asp homozygous subjects that were already diabetic. In this way, the healthy 
ICA-h population may be slightly enriched at the initial survey with those I C A + 
individuals who will not become diabetic. 
In the Barts-Windsor family study, the cumulative risk for I D D M in the 
non-diabetic relatives was associated with haplotype sharing of diabetes associated 
haplotypes, i.e. H L A - D R B 1*03 and H L A - D R B 1*04 positivity (Tarn et a l . , 1988). 
Our study is the first to analyze the association of polymorphisms at position 57 of 
the HLA-DQß chain and I C A positivity. In our population survey, high levels of 
I C A , i.e. greater than or equal to 17 and/or 30 J D F units, respectively, were found 
more often in non-Asp positives. Individuals with an A s p + H L A haplotype had 
lower levels of I C A . A t the population level we were also able to demonstrate that 
retesting for I C A after several months was required to demonstrate I C A persistency 
which was closely correlated with the immunogenetic I D D M marker non-Asp at 
codon 57 of the DQß chain. 
We show here for the first time that the molecular basis for the presence of 
cytoplasmic islet cell antibodies in a random population may be H L A haplotypes 
with non-charged amino acids at position 57 of the HLA-DQß chain. The observed 
H L A risk factors, which were also prevalent in the local group of I D D M patients, 
were not only associated with I C A positivity but also with the persistence of 
circulating islet cell antibodies. 
The genetic control of the antibody response was shown to depend on so-called 
immune response genes (Ir-genes); (Levine et a l . , 1963; McDevitt et a l . , 1965). A 
complex of Ir-genes and antigen directs the T-cell reaction (Wraith et a l . , 1989). In 
organ specific autoimmune diseases, autoantibody produetion is suggested to be 
dependent on specific T-cell help and more directly on the antigen binding of 
immunogenic peptides by the H L A molecules (Buus et a l . , 1987; Zwollo et a l . , 1991). 
The herein described H L A risk markers may be associated with factors that provide 
help for the generation of autoantibodies or may be associated with the lack of ß-cell 
specific suppressor phenomena. We favour the hypothesis that the observed H L A 
risk factors may be involved in the regulation of the immune response against islet 
cell antigens. T-cell cloning, the further characterization of the, to date, poorly 
characterized islet cell antigens, will help to clarify this question (Pankewycz et a l . , 
1991). 
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